Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mevacor Study Comparing Rx And OTC Use Is Among FDA Panel Suggestions

Executive Summary

Merck should conduct a head-to-head comparison study of Mevacor in prescription and over-the-counter settings, Endocrinologic and Metabolic Drugs Advisory Committee member William Tamborlane, MD, said during a review of Merck's OTC switch application for Mevacor.

You may also be interested in...



Mevacor Rx-To-OTC Switch Needs More Study, Committees Advise

J&J/Merck's proposed nonprescription statin Mevacor Daily is likely to require more research to reach over-the-counter status after a joint FDA advisory committee found flaws in the sponsors' actual-use CUSTOM study

Mevacor Rx-To-OTC Switch Needs More Study, Committees Advise

J&J/Merck's proposed nonprescription statin Mevacor Daily is likely to require more research to reach over-the-counter status after a joint FDA advisory committee found flaws in the sponsors' actual-use CUSTOM study

Zocor OTC Switch Sought In U.K.; Merck’s First Choice For U.S. Is Mevacor

Merck continues to favor Mevacor as its primary OTC switch candidate for the U.S. statin market despite a favorable recommendation by the British Department of Health to sell Zocor over the counter in the U.K

Related Content

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel